What's Good for Diabetes May Be Good for the Heart
For those with type 2 diabetes, keeping blood sugar levels under control can seem like walking a tightrope. But that delicate balancing act may benefit more than just blood sugar.
Cholesterol Rx and Stroke: The Effects on Older Patients
If you have to take a pill for high cholesterol, it would be nice to know that it does double duty. New evidence suggests that for healthy older patients, cholesterol drugs might have some benefits beyond just lowering cholesterol.
Blocked Arteries Might Affect Rx Effects
When statin medications don’t work, check the arteries. They may not work because the arteries are blocked.
Kidney Patients Who Need Statins Might Not Take Them
Two major health groups recommend statins for many patients with chronic kidney disease. But a new study found that many patients who should take statins didn't take them — even after a doctor recommended that they do so.
Cholesterol Rx May Be Lifesaver for Diabetes Patients
For those with Type 2 diabetes, heart disease is a major cause of death. Cholesterol-cutting statins, however, may help fight heart disease and prolong lives.
Many Not Getting Statins When They May Benefit
People take statin medications to fight high cholesterol. While these medications also may help those with high heart risks but not high cholesterol, statins are not always prescribed to those patients.
Statins Reduce More Than Cholesterol
Statins are effective and popular cholesterol-lowering medications. But they also have some possible side effects, including memory loss and high blood sugar. Now lower testosterone may join the list.
Cholesterol Drug Trilipix May Not Lower Heart Risk
U.S. Food and Drug Administration officials have announced that cholesterol-lowering drug fenofibric acid (Trilipix) might not lower a patient's risk of having a heart attack or stroke.
(UPDATE 12/15) FDA Announces New Safety Recommendations For High-Dose Simvastatin
The U.S. Food and Drug Administration today is announcing safety label changes for the cholesterol-lowering medication simvastatin because the highest approved dose--80 milligram (mg)--has been associated with an elevated risk of muscle injury or myopathy , particularly during the first 12 months of use.